Cure My Disease

Don't miss your cure!

 Log in / Sign up

First human trial launches for new oral cancer pill

NCT ID NCT07241039

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This is a first-in-human study to test the safety and early effectiveness of a new oral drug called ABBV-711, given alone or in combination with another drug, for adults with advanced squamous tumors. The trial is for people with cancers like certain lung or head and neck cancers who have progressed after standard treatments. Researchers will test different doses to see how the body handles the drug and if it helps control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SQUAMOUS TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Carolina BioOncology Institute /ID# 272380

    RECRUITING

    Huntersville, North Carolina, 28078, United States

  • City Of Hope Comprehensive Cancer Center /ID# 276550

    RECRUITING

    Duarte, California, 91030, United States

  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278432

    RECRUITING

    Irvine, California, 92618, United States

  • Hadassah Medical Center-Hebrew University /ID# 276800

    RECRUITING

    Jerusalem, 91120, Israel

  • Kansai Medical University Hospital /ID# 276586

    RECRUITING

    Hirakata-shi, Osaka, 573-1191, Japan

  • Next Oncology - Irving /ID# 276659

    RECRUITING

    Irving, Texas, 75039, United States

  • Rambam Health Care Campus- Haifa /ID# 276799

    RECRUITING

    Haifa, 3525408, Israel

  • START Midwest /ID# 272505

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • The Chaim Sheba Medical Center /ID# 276798

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

Conditions

Explore the condition pages connected to this study.

ADVANCED SQUAMOUS TUMORS